Laura Folguera-Trives

Madrid, MD, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Choroidal thickness as a biomarker of inflammatory activity in patients with polymyalgia rheumatica receiving anti-IL-6 treatment.

Choroidal thickness as a biomarker of inflammatory activity in patients with polymyalgia rheumatica receiving anti-IL-6 treatment.

Journal: Frontiers in medicine

Published: June 23, 2026

Prevalence of Psoriatic Arthritis in Patients with Moderate-to-Severe Psoriasis in the Era of Biologics and Small Molecule Therapies.

Prevalence of Psoriatic Arthritis in Patients with Moderate-to-Severe Psoriasis in the Era of Biologics and Small Molecule Therapies.

Journal: Journal of clinical medicine

Published: October 09, 2025

Choroidal thickness as a biomarker of systemic inflammation in patients with polymyalgia rheumatica.

Choroidal thickness as a biomarker of systemic inflammation in patients with polymyalgia rheumatica.

Journal: Frontiers in medicine

Published: August 20, 2025

Perception of COVID-19 vaccines in rheumatology patients.

Perception of COVID-19 vaccines in rheumatology patients.

Journal: Medicine

Published: April 08, 2025

Incidence and reasons for biologic and targeted synthetic DMARD switching in juvenile idiopathic arthritis: a real- life stratified analysis.

Incidence and reasons for biologic and targeted synthetic DMARD switching in juvenile idiopathic arthritis: a real- life stratified analysis.

Journal: Pediatric rheumatology online journal

Published: February 13, 2025

Real life treatment in juvenile idiopathic arthritis: Is remission long lasting?

Real life treatment in juvenile idiopathic arthritis: Is remission long lasting?

Journal: Reumatologia clinica

Published: December 09, 2024

Impact in Clinical Practice of the European Medicines Agency Health Alert About the Restriction of the Use of JAK Inhibitors.

Impact in Clinical Practice of the European Medicines Agency Health Alert About the Restriction of the Use of JAK Inhibitors.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 19, 2024

What to Expect When Systemic Treatment in Juvenile Idiopathic Arthritis Is Withdrawn?

What to Expect When Systemic Treatment in Juvenile Idiopathic Arthritis Is Withdrawn?

Journal: The Journal of rheumatology

Published: May 19, 2023

Oral or pulse glucocorticoid use at the onset of giant cell arteritis and its influence on the risk of relapse: a retrospective study.

Oral or pulse glucocorticoid use at the onset of giant cell arteritis and its influence on the risk of relapse: a retrospective study.

Journal: Rheumatology international

Published: November 21, 2022

A curious case of granulomatosis with polyangiitis: prostatic and skin involvement.

A curious case of granulomatosis with polyangiitis: prostatic and skin involvement.

Journal: Rheumatology advances in practice

Published: January 18, 2022

Persistence and adherence to biologic therapies in juvenile idiopathic arthritis.

Persistence and adherence to biologic therapies in juvenile idiopathic arthritis.

Journal: Scientific reports

Published: March 25, 2021

Subclavian artery involvement in patients with giant cell arteritis: do we need a modified Halo Score?

Subclavian artery involvement in patients with giant cell arteritis: do we need a modified Halo Score?

Journal: Clinical rheumatology

Published: November 04, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026